1,084 results match your criteria: "Tumor Hospital of Guangxi Medical University[Affiliation]"

Background: Muscle-invasive bladder cancer (MIBC) is a prevalent cancer characterized by molecular and clinical heterogeneity. Assessing the spatial heterogeneity of the MIBC microenvironment is crucial to understand its clinical significance.

Methods: In this study, we used imaging mass cytometry (IMC) to assess the spatial heterogeneity of MIBC microenvironment across 185 regions of interest in 40 tissue samples.

View Article and Find Full Text PDF

Background: Head and neck squamous cell carcinoma (HNSCC) is a prevalent form of cancer globally, with chemoresistance posing a major challenge in treatment outcomes. The efficacy of the commonly used chemotherapeutic agent, cisplatin, is diminished in patients with poor prognoses.

Methods: Various bioinformatics databases were utilized to examine Carboxylesterase 1 (CES1) gene expression, clinicopathologic features, patient survival analysis, and gene function.

View Article and Find Full Text PDF

Pathogenesis and Biomarkers of Cancer-Related Ischemic Stroke.

J Inflamm Res

November 2024

Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, People's Republic of China.

Objective: To investigate the pathogenesis of cancer-related ischemic stroke (CRIS) and to search for reliable biomarkers of CRIS.

Methods: Patients with CRIS, only-cancer and only-ischemic stroke who were hospitalized in the First Affiliated Hospital of Guangxi Medical University from May 2022 to January 2024 were recruited, and laboratory and clinical data of the three groups were collected. Peripheral venous blood was collected and enzyme-linked immunosorbent assay (ELISA) was used to detect markers of coagulation (D-dimer) and endothelial integrity (intercellular adhesion molecule-1 (ICAM-1)).

View Article and Find Full Text PDF
Article Synopsis
  • This study developed a machine-learning algorithm to predict survival rates for patients with gastric neuroendocrine neoplasms (gNENs) using data from 775 patients.
  • The researchers utilized various machine learning models, identifying the optimal random survival forest (RSF) model, which showed high predictive accuracy for 1-, 3-, and 5-year survival rates calculated from demographic and clinical data.
  • The final model allowed for risk stratification, classifying patients into high- and low-risk groups based on predicted outcomes, confirmed by Kaplan-Meier analysis for survival comparison.
View Article and Find Full Text PDF

Objective: The objective of this study is to develop and validate an effective prognostic nomogram for predicting the short-term survival rate of patients with acute heart failure (AHF) complicated by acute kidney injury (AKI) who are admitted to the intensive care unit (ICU).

Patients And Methods: We conducted an analysis of data from patients of AHF with AKI spanning the period from 2008 to 2019, utilizing the MIMIC-IV database. Patients were randomly divided into training and validation sets.

View Article and Find Full Text PDF

Tumor vascular occlusion by calcium-based thermosensitizer provokes continuous cavitation effect and thermal energy transition efficiency of radiofrequency ablation therapy.

Biomaterials

April 2025

Department of Hepatobiliary Surgery, Department of Medical Ultrasound, Tumor Hospital of Guangxi Medical University, Guangxi Medical University, No. 71 Hedi Road, Nanning, 530021, Guangxi, China. Electronic address:

Radiofrequency ablation (RFA) therapy for hepatocellular carcinoma (HCC) suffers from incomplete ablation with tumor remnants, recurrence, and metastasis. To capture these matters, a calcium-based thermosensitizer (CBT) was constructed, which can swell the thermal ablation treatment. DMXAA was encapsulated within CaCO nanoparticles and surface-modified using PEG.

View Article and Find Full Text PDF

Calf circumference-albumin index significantly predicts the prognosis of older patients with cancer cachexia: A multicenter cohort study.

Nutrition

January 2025

Department of Epidemiology and Statistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China; Henan Key Laboratory of Tumor Epidemiology, Zhengzhou University, Zhengzhou, Henan, China; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, China. Electronic address:

Article Synopsis
  • - The study evaluated the combined prognostic value of calf circumference (CC) and serum albumin to predict mortality in cancer cachexia patients aged 65 and older, utilizing a new index called the calf circumference-albumin (CCA) index.
  • - Involving 5322 older patients, results showed that the CCA index was more effective at predicting mortality compared to using CC or albumin alone, with better differentiating power indicated by a C index of 0.639.
  • - The CCA index, especially in patients with higher scores, significantly correlated with lower mortality rates, suggesting its potential for improved clinical management of older cancer patients experiencing cachexia.
View Article and Find Full Text PDF
Article Synopsis
  • - Over the last 30 years, miniaturized percutaneous nephrolithotomy (mPCNL) has gained popularity due to its potential to reduce complications compared to standard procedures, but there's still debate over best practices and management strategies that hinders wider use.
  • - An international panel of urology experts developed a consensus document on mPCNL to provide a comprehensive framework for practice, which included reviewing literature, identifying research gaps, and conducting surveys to gather expert opinions.
  • - The study revealed 58 key questions on mPCNL practices, and consensus was achieved on 30 questions, affirming mPCNL as an effective technique for treating upper urinary tract stones in both adults and children.
View Article and Find Full Text PDF

Systemic longitudinal immune profiling identifies proliferating Treg cells as predictors of immunotherapy benefit: biomarker analysis from the phase 3 CONTINUUM and DIPPER trials.

Signal Transduct Target Ther

October 2024

Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, PR China.

Article Synopsis
  • * It identifies a specific population of Ki67 proliferating regulatory T cells that express immunosuppressive markers, which correlates with treatment outcomes; higher levels were seen in patients who relapsed.
  • * The findings indicate that low baseline levels of these Ki67 Tregs can predict the effectiveness of immunotherapy, and similar results were confirmed in two other trials, suggesting a potential for personalized treatment strategies.
View Article and Find Full Text PDF

Background: Acute kidney injury (AKI) is a common and serious complication in patients with acute non-variceal upper gastrointestinal bleeding (NVUGIB). Early prediction and intervention are crucial for improving patient outcomes.

Methods: Data for patients presenting with acute NVUGIB in this retrospective study were sourced from the MIMC-IV database.

View Article and Find Full Text PDF

Background: Hypoxic conditions in glioma are linked to tumor aggressiveness, poor prognosis, and treatment resistance. Long non-coding RNAs (lncRNAs) play key roles in the hypoxic and immune microenvironment of cancers, but their link to hypoxia-induced immunosuppression in high-grade glioma (HGG) is not well-studied.

Methods: Gene expression profiles from TCGA and CGGA, along with clinical and genomic data, were analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • Muscle invasive bladder cancer (MIBC) is a serious condition associated with high rates of metastasis and limited treatment options, where immune checkpoint inhibitors (ICIs) show potential as a new therapy.
  • A detailed analysis of tumor samples identified specific cancer stem cell-like populations, particularly those expressing IGF2BP3, which are linked to immune suppression and poorer survival outcomes in MIBC patients.
  • Research on IGF2BP3 revealed its significant role in regulating key genes and pathways, suggesting that targeting this gene could be vital for developing more effective immunotherapy strategies against MIBC.
View Article and Find Full Text PDF

Single cell RNA-Sequencing Reveals Mast Cells Enhance Mononuclear Phagocytes Infiltration in Bladder Cancer Microenvironment.

J Cancer

September 2024

Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, Guangxi, China.

Investigating the interaction between Mast cells (MCs) and Mononuclear Phagocytes (MPs) in the tumor microenvironment (TME) of blader cancer (BCa) to uncover potential immunotherapeutic targets. Single-cell RNA sequencing (scRNA-Seq) was conducted on 12 BCa patients to identify distinct subgroups of MCs and MPs. Transcriptome data was analyzed to characterize the phenotype, gene enrichment, cell-cell communication, and biological processes.

View Article and Find Full Text PDF

Background: Manganese ions (Mn) combined with adjuvants capable of damaging and lysing tumor cells form an antitumor nano-modulator that enhances the immune efficacy of cancer therapy through the cascade activation of the cyclic GMP-AMP interferon gene synthase-stimulator (cGAS-STING) pathway, which underscores the importance of developing antitumor nano-modulators, which induce DNA damage and augment cGAS-STING activity, as a critical future research direction. METHODS AND RESULTS: We have successfully synthesized an antitumor nano-modulator, which exhibits good dispersibility and biosafety. This nano-modulator is engineered by loading manganese dioxide nanosheets (M-NS) with zebularine (Zeb), known for its immunogenicity-enhancing effects, and conducting targeted surface modification using hyaluronic acid (HA).

View Article and Find Full Text PDF

Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial.

Signal Transduct Target Ther

August 2024

Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.

Dual inhibition of vascular endothelial growth factor and epidermal growth factor receptor (EGFR) signaling pathways offers the prospect of improving the effectiveness of EFGR-targeted therapy. In this phase 3 study (ClinicalTrial.gov: NCT04028778), 315 patients with treatment-naïve, EGFR-mutated, advanced non-small cell lung cancer (NSCLC) were randomized (1:1) to receive anlotinib or placebo plus gefitinib once daily on days 1-14 per a 3-week cycle.

View Article and Find Full Text PDF

Unveiling potential: urinary exosomal mRNAs as non-invasive biomarkers for early prostate cancer diagnosis.

BMC Urol

August 2024

Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Medical University, No.22 Shuangyong Road, Qingxiu District, Nanning, Guangxi, 530021, P.R. China.

Article Synopsis
  • The study explored urinary exosomal mRNA as a potential early biomarker for prostate cancer (PCa), comparing samples from individuals with and without cancer.
  • Utilizing next-generation sequencing and further validation with qRT-PCR, researchers identified specific mRNAs, particularly RAB5B and WWP1, that showed promise in distinguishing PCa patients from healthy individuals.
  • The combination of RAB5B and WWP1 outperformed traditional PSA tests with a high area under the curve (AUC) value of 0.923, suggesting that this method could significantly enhance early detection of PCa.
View Article and Find Full Text PDF

Objective: To examine the influence of Saponin I from Shuitianqi () (SSPH I) on hepatocellular carcinoma (HCC) metastasis, and to elucidate the underlying mechanism.

Methods: The intrahepatic metastasis Bagg's Albino/c (BALB/c) mouse model was established with human hepatocellular carcinomas (HepG2) cells, then treated with normal saline (once per day), cisplatin (2 mg/kg, once every 2 d), and SSPH Ⅰ (25, 50, and 75 mg/kg, once per day). Then, we assessed alterations in the hepatic pathology and target protein expressions in the intrahepatic metastasis BALB/c mouse model using a series of molecular biology techniques.

View Article and Find Full Text PDF

Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition).

J Natl Cancer Cent

December 2023

CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.

Article Synopsis
  • * About 50% of patients with bone metastasis face serious complications known as skeletal related events (SREs), which drastically affect their quality of life and survival.
  • * To improve diagnosis and treatment for bone metastasis in lung cancer, a multi-disciplinary team has created an expert consensus for standardizing care approaches.
View Article and Find Full Text PDF

AI-Based multimodal Multi-tasks analysis reveals tumor molecular heterogeneity, predicts preoperative lymph node metastasis and prognosis in papillary thyroid carcinoma: A retrospective study.

Int J Surg

July 2024

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thyroid Surgery, Department of Medical Oncology, Breast Tumor Centre, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Background: Papillary thyroid carcinoma (PTC) is the predominant form of thyroid cancer globally, especially when lymph node metastasis (LNM) occurs. Molecular heterogeneity, driven by genetic alterations and tumor microenvironment components, contributes to the complexity of PTC. Understanding these complexities is essential for precise risk stratification and therapeutic decisions.

View Article and Find Full Text PDF

Background: We found that the occurrence of hepatocellular carcinoma (HCC) has increased significantly in non-cirrhotic individuals, with HCC being frequently overlooked or misdiagnosed. Contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) is known to have a high diagnostic quality in high-risk HCC patients. Therefore, we aimed to compare the detection accuracy of CEUS LI-RADS for HCC between low- and high-risk individuals, to confirm its value in low-risk patients at increased risk of HCC, but not yet included in the high-risk groups of LI-RADS.

View Article and Find Full Text PDF

Rheumatoid arthritis (RA) is an autoimmune disease causing progressive joint damage. Early diagnosis and treatment is critical, but remains challenging due to RA complexity and heterogeneity. Machine learning (ML) techniques may enhance RA management by identifying patterns within multidimensional biomedical data to improve classification, diagnosis, and treatment predictions.

View Article and Find Full Text PDF

Disulfidptosis-related genes serve as potential prognostic biomarkers and indicate tumor microenvironment characteristics and immunotherapy response in prostate cancer.

Sci Rep

June 2024

Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-Constructed By the Province and Ministry, Guangxi Medical University, No. 22, Shuangyong Road, Qingxiu District, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.

Disulfidptosis, a newly identified programmed cell death pathway in prostate cancer (PCa), is closely associated with intracellular disulfide stress and glycolysis. This study aims to elucidate the roles of disulfidptosis-related genes (DRGs) in the pathogenesis and progression of PCa, with the goal of improving diagnostic and therapeutic approaches. We analyzed PCa datasets and normal tissue transcriptome data from TCGA, GEO, and MSKCC.

View Article and Find Full Text PDF

Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.

Lancet

June 2024

Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China; Chinese Society of Clinical Oncology, Beijing, China. Electronic address:

Article Synopsis
  • This clinical trial explored the effectiveness of adding sintilimab, a PD-1 inhibitor, to standard chemoradiotherapy for patients with high-risk, locoregionally advanced nasopharyngeal carcinoma.
  • Results showed that the sintilimab group had significantly better event-free survival rates compared to the standard therapy group at a median follow-up of nearly 42 months.
  • The trial also reported that a high percentage of patients experienced grade 3-4 adverse events, indicating a need for monitoring side effects in this treatment approach.
View Article and Find Full Text PDF

Efficacy and Safety of Taletrectinib in Chinese Patients With Non-Small Cell Lung Cancer: The Phase II TRUST-I Study.

J Clin Oncol

August 2024

Department of Medical Oncology, Shanghai Pulmonary Hospital and Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China.

Article Synopsis
  • Taletrectinib is a potent drug for treating non-small cell lung cancer that has shown high response rates and safety, particularly effective against the G2032R mutation.
  • In the TRUST-I study, 91% of treatment-naïve patients and 52% of those who had been treated with crizotinib experienced confirmed responses, with a median response duration not yet reached for naïve individuals.
  • The treatment's side effects were mostly mild, with low rates of severe neurologic issues, making it a promising option for patients with advanced lung cancer in China.
View Article and Find Full Text PDF